tiprankstipranks
Ramm Pharma (TSE:RAMM)
:RAMM
Canadian Market
RAMM
Ramm Pharma
RESEARCH TOOLSreports

Ramm Pharma (RAMM) Income Statement

1 Followers

Ramm Pharma Income Statement

Last quarter (Q4 2025), Ramm Pharma's total revenue was C$605.66K, a decrease of -40.70% from the same quarter last year. In Q4, Ramm Pharma's net income was C$-7.16M. See Ramm Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jan 26Jan 25Jan 24Jan 23Jan 22
Total Revenue
C$ 3.36MC$ 4.34MC$ 5.07MC$ 3.90MC$ 4.12M
Gross Profit
C$ 373.93KC$ 1.76MC$ 381.82KC$ 530.50KC$ -7.64K
Operating Expenses
C$ 4.89MC$ 8.52MC$ 7.47MC$ 8.46MC$ 6.63M
Depreciation and Amortization
C$ 734.76KC$ 1.21MC$ 1.34MC$ 1.02MC$ 732.63K
EBITDA
C$ -3.78MC$ -15.23MC$ -6.30MC$ -19.91MC$ -6.36M
Operating Income
C$ -4.52MC$ -6.76MC$ -7.09MC$ -7.93MC$ -7.19M
Other Income/Expenses
C$ -4.38MC$ -9.73MC$ -625.08KC$ -13.02MC$ 92.01K
Pretax Income
C$ -8.89MC$ -16.49MC$ -7.71MC$ -20.95MC$ -7.10M
Net Income
C$ -8.91MC$ -16.50MC$ -7.72MC$ -20.96MC$ -7.11M
Per Share Metrics
Basic EPS
C$ -0.07C$ -0.14C$ -0.06C$ -0.17C$ -0.07
Diluted EPS
C$ -0.07C$ -0.14C$ -0.06C$ -0.17C$ -0.07
Weighted Average Shares Outstanding
 119.39M 119.39M 121.04M 122.77M 108.46M
Weighted Average Shares Outstanding (Diluted)
 119.39M 119.39M 121.04M 122.77M 108.46M
Currency in CAD

Ramm Pharma Earnings and Revenue History